ABSTRACT DNA fragments from Pseudomonas aeruginosa carrying the PaeR7 restriction/modification genes have been cloned in the plasmid vector pBR322 and propagated in Escherichia coli A subclone (pPAORM3.8) has been constructed that contains the complete restriction/modification system on a 3.8-kilobase DNA fragment. Digestion of the pPAORM3.8 plasmid with nuclease BAL-31 has yielded two types of clones. One type contains an active methylase gene but no active endonuclease gene; such clones will modify the DNA but not restrict the growth of incoming phage in vivo. The second type contains an active endonuclease gene but no active methylase gene, as judged both by in vivo tests and by the activity ofthe cell extracts in vitro. Although extracts of cells containing these plasmids display restriction endonuclease activity, these bacteria are unable to restrict the growth ofincoming phage. Furthermore, chromosomal and phage DNA isolated from these host cells are not protected against cleavage by PaeR7 in vitro. The properties of PaeR7 endonuclease and methylase enzymes have also been examined. The PaeR7 restriction endonuclease recognizes and cleaves the sequence C J T-C-G-A-G, as does Xho I. However, there exists a canonical Xho I site at 26.5% on the adenovirus 2 genome which is totally refractory to PaeR7 cleavage but is cut by Xho I. Under conditions of low salt, high glycerol, and high enzyme concentrations, a "PaeR7*" activity is found that is similar to that observed for EcoRI. Finally, evidence is presented that the PaeR7 methylase modifies the adenine residue within the recognition sequence.
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In many bacteria, restriction/modification systems produce strain-specific enzymes that allow host cells to recognize and destroy foreign DNA. This is accomplished by a restriction endonuclease that makes double-strand scissions at a limited number of specific sites on the DNA. In addition to restriction activity, such bacterial strains possess a corresponding DNA methylase that modifies specific adenine or cytosine residues within the sequence recognized by the nuclease. The methylation protects the cell's DNA against the action of its own restriction enzymes (1) (2) (3) (4) .
The genes for restriction/modification systems may be encoded on chromosomal, phage, or plasmid DNAs (1). The PaeR7 system belongs to the third category. It is encoded by a 42-kilobase (kb) plasmid, pMG7, carried in Pseudomonas aeruginosa (5) . We were able to use the system's plasmid location to facilitate its cloning.
We have used molecular cloning to transfer the PaeR7 restriction/modification system into Escherichia coli. Furthermore, we have been able to divide the system and generate two types of subclones: those that express only the methylase gene, and those that express only the endonuclease gene. The viability of the latter class of clones is surprising because the chromosomal DNA from these clones is susceptible to PaeR7 cleavage. (9) . Adenovirus type 2 (Ad2) DNA was prepared by the method of Pettersson and Sambrook (10) . pBR322 derivatives (pX164 and pX2281) containing Xho I linkers at positions 164 and 2,281, respectively, were supplied by T. J. Kwoh.
Restriction Enzymes and 5' Mono-and Dinucleotide Analysis. The restriction endonucleases Sal I, HincII, BstNI, EcoRI, BamHI, HindIII, Pst I, Nru I, Xho I, and Xma I were obtained from New England Biolabs. Digestions using these enzymes were performed under conditions recommended by the manufacturer. Kpn I, Rsa I, Bcl I, and PaeR7 were prepared by P. Myers in this laboratory. Kpn I, Rsa I, and Bcl I digestions were performed in buffer containing 6 mM Tris, pH 7.9/6 mM SHCH2CH2OH/6 mM MgCl2. PaeR7 digestions were done in 150 mM NaCl/6 mM Tris, pH 7.9/6 mM MgCl2/6 mM SHCH2CH20H containing 100 ,g of bovine serum albumin per ml (final volume, 50 ,ul) at 37°C for 2 hr. PaeR7* digestions were performed in 6 mM Tris, pH 7.9/6 mM MgCl2/6 mM SHCH2CH2OH/20% (vol/vol) glycerol, with an excess of PaeR7 enzyme; incubation was for 12 hr at 37°C.
Calf alkaline phosphatase and T4 polynucleotide kinase (Boehringer Mannheim) were used to label the 5' ends of DNA fragments generated by Xho I and PaeR7 as described by Chaconas and van de Sande (11). The 5' mononucleotides and dinucleotides from 5' 32P-end-labeled Xho I and PaeR7 fragments were determined by using snake venom phosphodiesterase and exonuclease I (Sigma) followed by high-voltage electrophoresis (12) .
Construction of Clones. pBR322 plasmids carrying DNA fragments from pMG7 were constructed by digesting pMG7 DNA (1 ,ug) with BamHI and ligating the resulting fragments to phosphatase-treated BamHI-cleaved pBR322 (0.1 ,ug) by using T4 DNA ligase. E. coli MM294 cells (=5 X 109) were transformed by the CaCl2/heat-shock method of Cohen et al. (13) . Transformants were selected on LB agar plates containing 100 ,ug of ampicillin per ml. A total of 27 transformants were Abbreviations: kb, kilobase(s); Ad2, adenovirus type 2.
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pPAORM3.8 was prepared by digesting 2 pug of pPAORM38b with Nru I. The resulting fragments were recircularized with T4 ligase and used to transform MM294.
Further deletions were made in this subelone by treatment of the plasmid DNA with BAL-31. Ten micrograms of pPAORM3.8 DNA (Fig. 1) was linearized with either BamHI or Nru I, and the DNA was treated with 2 units of BAL-31 nuclease (Bethesda Research Laboratories) under conditions recommended by the manufacturer. Aliquots (10-pl) were removed at intervals of 30 sec and 1, 2, 3, and 5 min. To each aliquot was added 20 p1L of 100 mM EDTA to stop the reaction, and the samples were phenol treated and precipitated. The ends of the BAL-31-treated DNA fragments (2 pug) were repaired by using 1.4 units of the Klenow subfragment of DNA polymerase I (New England Biolabs) at 12'C for 45 min. In the case of pPAORM3.8 DNA opened at the BamHI site, the repaired blunt-ended fragments were religated with T4 ligase by incubation at 40C for 24 hr. With plasmids opened at the Nru I site, the repaired blunt-ended fragments were ligated to Sal I linkers (Collaborative Research, Waltham, MA; ratio of ends to linker, 1:20) and cleaved with Sal I, and the complementary ends of the Sal I site rejoined by T4 ligase to recircularize the plasmid.
Assays of Restriction and Modification Enzymes. (a) In vitro assays. Extracts were prepared from 5.0 ml of transformed or control cells to detect the presence of the restriction or modification enzymes. After low-speed centrifugation, cells were resuspended in 500 u1l of 10 mM Tris, pH 7.6/10 mM SHCH2CH2OH/10 mM EDTA containing 0.5 mg of lysozyme and subjected to a cycle offreezing and thawing followed by 15 sec of sonication to disrupt the cell wall. MgCl2 was added to a final concentration of 10 mM and the cell debris and DNA was pelleted by centrifugation. PaeR7 endonuclease activity was tested by digesting 2 ,ug of Ad2 with 4 ,ul of extract at 37C for 10 min. The digestion products were analyzed by electrophoresis (14) . PaeR7 methylase activity was tested by incubating (37°C; 30 min) 1 ,ug of Ad2 DNA with 10 ,ul of cell extract in a 50-plI reaction mixture containing 50 mM Tris (pH 7.5), 10 mM EDTA, 10 mM SHCH2CH2OH, and 0.1 mM S-adenosylmethionine. As a control the DNA was treated similarly but in the absence of S-adenosylmethionine. The Ad2 DNA was purified by phenol extraction and ethanol precipitation, challenged with PaeR7 or Xho I under conditions described above, and analyzed on a 1% agarose gel.
(b) In vivo assays. Transformants were screened for the ability to restrict and modify 480 phage in vivo. To test for restriction, aliquots (0.1 ml) of transformant cultures were spot-tested with a dilution series from a high-titer phage stock, as described by Mann et aL (15) . To test for phage modification, phage were picked from plaques on the transformed host and resuspended in 1 ml of 10 mM Tris, pH 7.4/5 mM MgCl2/0.2 M NaCl/ 0.1% gelatin equilibrated with chloroform; the phage were serially diluted and spotted on both nonrestricting (MM294) and restricting [MM294 (pPAORM38b)] host cells.
Nomenclature. A standard method for naming plasmids containing restriction or modification genes has been adopted. Plasmids are described by: "p" for plasmid; the three letter abbreviation ofthe restriction/modification system (PAO); "R" for the restriction gene, "M" for the methylase gene, or "RM" for both genes;,ancla numeral for the size of the insert in kb. For example, a plasmid carrying both the restriction and modification genes from P. aeruginosa on a 3.8-kb insert is named "pPAORM3.8." Multiple plasmids containing the same complement of restriction or modification genes or both on the same-size insert fragment are further denoted by a letter after the size designation (see below).
RESULTS

Properties ofPaeR7
Clones. The initial transfer ofthe PaeR7 restriction/modification system into E. coli was accomplished by ligating BamHI fragments of pMG7 to pBR322 (Fig. 1 ). All clones generated were then tested for restriction and modification both in vivo and in vitro. Three types of plasmids were of interest: pPAORM42, containing the complete pMG7 (42-kb) inserted into pBR322; pPAORM38a, containing a 38-kb fragment ofpMG7 ligated to pBR322; and pPAORM38b, containing the same 38-kb fragment but ligated to pBR322 in the opposite orientation. All three types of clones produced PaeR7 endonuclease and methylase as shown by in vitro assays (Fig. 2) Subelones derived from pPAORM38a and pPAORM38b were prepared by restriction enzyme cleavage and religation to generate smaller plasmids containing the restriction/modification system. The smallest ofthese constructs, pPAORM3.8, contained a 3.8-kb fragment from pMG7. It both restricted and modified the DNA of 480 phage as well as produced large quantities of PaeR7 endonuclease and methylase (Fig. 2) .
To reduce further the size of the insert and to determine the order ofthe restriction/modification genes within this segment of DNA, the pPAORM3.8 plasmid was opened at either the BamHI or Nru I site, treated with BAL-31 nuclease, and then religated. The smallest ofthe clones generated by BAL-31 treatment at the Nru I site contained a 2.7-kb fragment from pMG7 ( Fig. 1 ). This plasmid, designated pPAOM2.7, made active methylase and modified the DNA of 480 phage; however, it no longer restricted incoming phage, nor did it contain endonuclease as judged by an in vitro assay (Fig. 2) . A more unusual set of clones were generated by BAL-31 treatment of BamHIcut pPAORM3.8. These clones made PaeR7 endonuclease but not methylase; they neither restricted nor modified the DNA of 480 phage (Fig. 2) . The smallest ofthese constructs contained a 1.9-kb insert and is designated pPAOR1.9 (Fig. 1) . A composite ofthe two sets ofBAL-31 clones indicated the order (from the BamHI site to the Nru I site) of the genes to be first the methylase and then the endonuclease gene.
The endonuclease+ modification-pPAORl.9 clone was characterized in several ways. It was determined whether chromosomal DNA from the pPAOR1.9-containing clone was protected against cleavage by PaeR7 (or its isoschizomer, Xho I). Chromosomal DNA isolated from the pPAOR1.9 clone was sensitive to cleavage by PaeR7 or Xho I (not shown) as was DNA from 080 phage grown in these cells (Fig. 3) . However, chromosomal and phage DNAs isolated from clones with the R'M' phenotype all were modified against PaeR7 and Xho I cleavage (Fig. 3) .
Despite the fact that chromosomal DNA from the pPAOR1.9 clone was unmodified, the clone was stable. There were no observable changes in plasmid structure (with respect to its restriction map) after three rounds of plasmid isolation and retransformation. In addition, secondary and tertiary transformants still produced restriction endonuclease at the same level.
Properties of the PaeR7 Endonuclease. It had previously been noted that PaeR7 and Xho I have a common recognition sequence, C-T-C-G-A-G (ref. 16 (Fig. 4A ). This is due to the inability of PaeR7 to cleave one of the Xho I sites on the Ad2 genomei.e., the site located at nucleotide 9 Experiments were performed with DNA containing the Ad2 26% site to determine what properties were responsible for blocking cleavage. When. ligated to DNA from a different source, "hybrid" sites containing sequences from the right side (toward higher Ad2 map positions) of the 26% site were cleavable by both Xho I and PaeR7. However, a hybrid site containing sequences to the left (toward. lower map positions) of the original 26% site still was resistant to PaeR7 (Fig. 5) .
During efforts to optimize digest conditions for PaeR7, a sec-
CCT C T C G A TT.T.T. G..G.A.GAG T ond endonucleolytic activity was observed in PaeR7 preparations. This activity was found under conditions of low salt, high glycerol, and high enzyme concentrations with prolonged incubation (Fig. 4B) . The second activity was inhibited by high salt (150 mM NaCI). Under identical digestion conditions, Xho I showed no secondary activity. Specificity of the PaeR7 Methylase. We determined which base is methylated within the PaeR7 recognition site by the method described' by McClelland (18) . Because the central tetranucleotide ofthe PaeR7 recognition site, T-C-G-A, is also the. Taq I recognition site (19) , all PaeR7 sites are also Taq I sites. It had been shown previously that Taq I cleavage is blocked by N6-methyladenine within its recognition site but is insensitive to the presence of 5-methylcytosine (18, 20) . Therefore, failure of Taq I to cleave a PaeR7 site after it had been modified by the PaeR7 methylase would indicate that this enzyme is a DNA adenine methylase. Taq I could not cleave a PaeR7 site (inserted as a Xho I linker into pBR322) after having been modified by the PaeR7 methylase (Fig. 6 ). This result strongly suggests that the PaeR7 methylase acts at the recognition site to produce 5' C-T-C-G-mA-G 3'. We have also noted that PaeR7 methylation can block cleavage of its recognition site by Xho I and Ava I (C-Py-C-G-Pu-G). However, this does not necessarily imply that these two enzymes have the same cognate methylation site (21) . DISCUSSION Efforts to clone the genes for various restriction/modification systems in E. coli have met with success in only four cases:
EcoRI (22) , EcoRII (23) , Hha II (15) , and Pst I (24) . It is uncertain why attempts to clone other systems have not succeeded. The fact that PaeR7 is a-type II system (25) which is plasmid-borne (5) facilitated the isolation and transfer of the genes. Clones containing the PaeR7 system also have been reported by Theriault and Roy (26) .
PaeR7 possesses some interesting properties. The inability of this enzyme to cleave the Ad2 26.5% site is a phenomenon which, to our knowledge, is unique (27, 28 A second possibility is that the PaeR7 restriction gene has undergone mutation and now codes for an altered protein that is nonfunctional under physiological conditions. There is a precedent for this-the occurrence of such a mutation in clones containing the EcoRI system. A spontaneous mutation in the endonuclease gene (30) resulted in a mutant that was unable to restrict incoming A phage; nevertheless, extracts of the mutant cells contained high levels ofendonuclease activity. The mutant form ofthe enzyme differs-from the wild type in optimal reaction parameters (P. Greene, personal communication). To determine whether a similar mutation has occurred in the PaeR7 system, it will be necessary to compare the DNA sequences ofthe restriction gene from pPAORL9 (endonuclease' methylase&) with the gene from pPAORMS.8 (endonuclease' methylase') digestion produced clones with inserts of variable length, all of which were endonuclease' methylase-. Therefore, a mutation altering the in vivo activity of the PaeR7 endonuclease gene would have to be common to all of these constructs.
The third possibility is that in the PaeR7 system the presence of the restriction endonucleasealone is not sufficient for in vivo activity. Another gene product may be required to elicit the in vivo activity. The control element, whatever its composition, may have evolved specifically to aid this plasmid-borne system during the transfer of the plasmid between different bacteria. The presence of a third factor would imply that type II restriction/modification systems are a more complex and diverse group than has been assumed.
